Detalhe da pesquisa
1.
Author Correction: The persistence of memory: defining, engineering, and measuring vaccine durability.
Nat Immunol
; 24(1): 200, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36572838
2.
The persistence of memory: defining, engineering, and measuring vaccine durability.
Nat Immunol
; 23(12): 1665-1668, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456737
3.
Casting a wider net: Immunosurveillance by nonclassical MHC molecules.
PLoS Pathog
; 15(2): e1007567, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30789961
4.
Leveraging lessons learned from the COVID-19 pandemic for HIV.
Commun Med (Lond)
; 2: 110, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045906
5.
Acute HIV-1 infection: what's new? Where are we going?
J Infect Dis
; 202 Suppl 2: S267-9, 2010 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20846032
6.
Challenges for rapid molecular HIV diagnostics.
J Infect Dis
; 201 Suppl 1: S1-6, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20225941
7.
Research productivity and collaboration of the NIH-funded HIV vaccine trials network: A bibliometric analysis.
Heliyon
; 7(1): e06005, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33532641
8.
Mind the gap from research laboratory to clinic: Challenges and opportunities for next-generation assays in human diseases.
Vaccine
; 39(37): 5233-5239, 2021 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34366145
9.
Engineering immunity for next generation HIV vaccines: The intersection of bioengineering and immunology.
Vaccine
; 38(2): 187-193, 2020 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31759734
10.
Author Correction: Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV-workshop report.
NPJ Vaccines
; 9(1): 61, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38485736
11.
Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV-workshop report.
NPJ Vaccines
; 9(1): 39, 2024 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38383616
12.
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop report.
NPJ Vaccines
; 8(1): 53, 2023 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37045860
13.
Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials.
AIDS Res Hum Retroviruses
; 21(1): 68-81, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15665646
14.
Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays.
J Immunol Methods
; 409: 62-71, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24801479
15.
The External Quality Assurance Oversight Laboratory (EQAPOL) proficiency program for IFN-gamma enzyme-linked immunospot (IFN-γ ELISpot) assay.
J Immunol Methods
; 409: 31-43, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24685833
16.
Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials.
J Immunol Methods
; 409: 107-16, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24787274
17.
Harnessing CD4⺠T cell responses in HIV vaccine development.
Nat Med
; 19(2): 143-9, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23389614
18.
Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells.
J Immunol Methods
; 375(1-2): 57-67, 2012 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-21968254
19.
Quality assurance of intracellular cytokine staining assays: analysis of multiple rounds of proficiency testing.
J Immunol Methods
; 363(2): 143-57, 2011 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20727897
20.
Current advances and challenges in HIV-1 vaccines.
Curr HIV/AIDS Rep
; 3(1): 39-47, 2006 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-16522258